Following a successful presentation at the Cell Therapy Manufacturing and Gene Therapy Congress in Brussels, Onyx has again had a strong presence at the prestigious World Orphan Drugs Congress in Washington. This emphasises Onyx strong and continuing commitment to the areas of orphan drugs, rare and ultra-rare diseases and regenerative medicine including cell and gene therapies.
Prime Global has appointed Sue O’Leary to lead their growing Market Access practice and support the business across the Group’s six full service medical communications agencies. She will be joined by Rebecca Massey, Senior Director, Global Market Access & HEOR.read more >>
The award-winning medical communications agency, Prime Global, has announced the relocation of their New York office. On September 9themployees will move from their office on 57thStreet to a larger, ultra-modern WeWork office on 9th Avenue, in the Hudson Yardsarea.read more >>